Kevin Jacoby | October 29, 2024 It has long been my opinion that the advertising restrictions applicable to Oregon’s cannabis advertising market were unconstitutional. On October 16, 2024, the Oregon Court of Appeals issued a decision in Bates v. Oregon Health...
Holon Law Partners September 9, 2024 In response to growing concerns about the risks posed by intoxicating hemp products to children, Governor Gavin Newsom announced proposed emergency regulations aimed at tightening controls over THC in industrial hemp products....
September 05, 2024 By Michael McQueeny Categories: Hemp , DEA The United States Court of Appeals for the Fourth Circuit ruled that the Drug Enforcement Agency’s (“DEA”) classification of certain hemp-derived cannabinoids as unlawful was not entitled to deference,...
September 9, 2024 Authors Adam J. Fromm , Clifford Cooper II This is an exciting time for cannabis entrepreneurs as the US government is poised to reclassify cannabis as a Schedule III drug in a move that recognizes cannabis’ medical and therapeutic uses and may open...
As the conversation surrounding the rescheduling of cannabis gains momentum, it is clear that we are at a pivotal moment in the history of cannabis regulation in the United States. Recent developments signal a potential shift in federal policy that could have...
AUTHOR Stephen Bartlett Partner Boston +1.617.832.3007 sbartlett@foleyhoag.com October 09, 2024 By Stephen L. Bartlett Given the high stakes and the significant market at risk, it is no surprise that hemp advocates and operators have aggressively challenged state...